insights_auto
Why is BHC down 3,97%?
Dive Deeperchevron_right
BHC:NYSE
Bausch Health Companies Inc
8,22 USD
arrow_downward
-3,97%(-0,34) 1D
8,21 USD
arrow_downward
-0,12% (-0,010)bedtimeAfter hours
Closed: 20-ноя., 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
8,42 USD
High
8,56 USD
Low
8,12 USD
Mkt. cap
3,09 млд
Avg. vol.
4,13 млн
Volume
3,84 млн
52-wk high
9,04 USD
52-wk low
4,33 USD
EPS
-2,29 USD
Beta
0,30
Shares outstanding
374,27 млн
No. of employees
20 миң
Open
8,42 USD
High
8,56 USD
Low
8,12 USD
Mkt. cap
3,09 млд
Avg. vol.
4,13 млн
Volume
3,84 млн
52-wk high
9,04 USD
52-wk low
4,33 USD
EPS
-2,29 USD
Beta
0,30
Shares outstanding
374,27 млн
No. of employees
20 миң
News stories
From web sources and news partners
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20,3 миң
Founded1959
HeadquartersЛаваль, Квебек, Канада
SectorHealth Care
IndustryPharmaceutical industry
Websitebauschhealth.com